JAY M. SHORT - 21 Jun 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Jay M. Short
Issuer symbol
BCAB
Transactions as of
21 Jun 2022
Transactions value $
$198,336
Form type
4
Filing time
23 Jun 2022, 16:59:33 UTC
Previous filing
06 May 2022
Next filing
01 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Purchase $81,040 +29,082 +2.23% $2.79 1,335,674 21 Jun 2022 Direct F1, F2
transaction BCAB Common Stock Purchase $117,296 +40,308 +3.02% $2.91 1,375,982 22 Jun 2022 Direct F1, F3
holding BCAB Common Stock 793,547 21 Jun 2022 By Spouse
holding BCAB Common Stock 258,727 21 Jun 2022 By Carolyn Short 2020 Irrevocable Gift Trust
holding BCAB Common Stock 258,727 21 Jun 2022 By Jay Short 2020 Irrevocable Gift Trust
holding BCAB Common Stock 302,324 21 Jun 2022 By Capia IP, LLC
holding BCAB Common Stock 50 21 Jun 2022 By Himalaya Parent LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The range of prices for the shares of Common Stock is from $2.68 to $2.87. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F3 The range of prices for the shares of Common Stock is from $2.70 to $3.02. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F4 The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.